{"nct_id":"NCT03197584","title":"QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy","status":"WITHDRAWN","status_verified_date":"2017-10","start_date":"2017-12","start_date_type":"ESTIMATED","primary_completion_date":"2019-02","primary_completion_date_type":"ESTIMATED","completion_date":"2021-12-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IBRX"]}